Literature DB >> 24019014

Extracellular vesicle-mediated transfer of membranous components from the highly malignant T24 urinary carcinoma cell line to the non-malignant RT4 urinary papilloma cell line.

Eva Ogorevc1, Samo Hudoklin, Peter Veranič, Veronika Kralj-Iglič.   

Abstract

This communication reports the first experimental evidence that in the bladder cancer model, membranous components labelled with the DiO dye and the cholera toxin subunit B can be transported from highly malignant (T24) to non-malignant (RT4) cells by extracellular vesicles. Taking into account the presence of stable membranous nanostructures found by scanning electron microscopy, we suggest a possible uptake mechanism in recipient cells through fusion with highly curved membranous regions.

Entities:  

Mesh:

Year:  2013        PMID: 24019014     DOI: 10.1007/s00709-013-0544-5

Source DB:  PubMed          Journal:  Protoplasma        ISSN: 0033-183X            Impact factor:   3.356


  12 in total

1.  Different types of cell-to-cell connections mediated by nanotubular structures.

Authors:  Peter Veranic; Marusa Lokar; Gerhard J Schütz; Julian Weghuber; Stefan Wieser; Henry Hägerstrand; Veronika Kralj-Iglic; Ales Iglic
Journal:  Biophys J       Date:  2008-07-25       Impact factor: 4.033

2.  Curvature factor and membrane solubilization, with particular reference to membrane rafts.

Authors:  Lucyna Mrówczyńska; Ulrich Salzer; Aleš Iglič; Henry Hägerstrand
Journal:  Cell Biol Int       Date:  2011-10       Impact factor: 3.612

3.  Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin.

Authors:  Chan Woo Kim; Hwan Myung Lee; Tae Hoon Lee; Chulhun Kang; Hynda K Kleinman; Yong Song Gho
Journal:  Cancer Res       Date:  2002-11-01       Impact factor: 12.701

Review 4.  Tumor cell-derived exosomes: a message in a bottle.

Authors:  Pedram Kharaziha; Sophia Ceder; Qiao Li; Theocharis Panaretakis
Journal:  Biochim Biophys Acta       Date:  2012-04-01

5.  Metastasis-associated alterations in phospholipids and fatty acids of human prostatic adenocarcinoma cell lines.

Authors:  R Dahiya; B Boyle; B C Goldberg; W H Yoon; B Konety; K Chen; T S Yen; W Blumenfeld; P Narayan
Journal:  Biochem Cell Biol       Date:  1992-07       Impact factor: 3.626

Review 6.  Dissecting lipid raft facilitated cell signaling pathways in cancer.

Authors:  Samir Kumar Patra
Journal:  Biochim Biophys Acta       Date:  2007-12-05

7.  Comparative lipid analysis of purified plasma membranes and shed extracellular membrane vesicles from normal murine thymocytes and leukemic GRSL cells.

Authors:  W J Van Blitterswijk; G De Veer; J H Krol; P Emmelot
Journal:  Biochim Biophys Acta       Date:  1982-06-14

8.  Oncogenic extracellular vesicles in brain tumor progression.

Authors:  Esterina D'Asti; Delphine Garnier; Tae H Lee; Laura Montermini; Brian Meehan; Janusz Rak
Journal:  Front Physiol       Date:  2012-07-24       Impact factor: 4.566

Review 9.  The immune functions of phosphatidylserine in membranes of dying cells and microvesicles.

Authors:  Benjamin Frey; Udo S Gaipl
Journal:  Semin Immunopathol       Date:  2010-10-13       Impact factor: 11.759

10.  Stability of membranous nanostructures: a possible key mechanism in cancer progression.

Authors:  Veronika Kralj-Iglic
Journal:  Int J Nanomedicine       Date:  2012-07-12
View more
  2 in total

Review 1.  Extracellular Vesicles as Biomarkers Carriers in Bladder Cancer: Diagnosis, Surveillance, and Treatment.

Authors:  Natalia Georgantzoglou; Alexandros Pergaris; Christos Masaoutis; Stamatios Theocharis
Journal:  Int J Mol Sci       Date:  2021-03-09       Impact factor: 5.923

2.  Autologous Platelet- and Extracellular Vesicle-Rich Plasma Is an Effective Treatment Modality for Chronic Postoperative Temporal Bone Cavity Inflammation: Randomized Controlled Clinical Trial.

Authors:  Domen Vozel; Darja Božič; Marko Jeran; Zala Jan; Manca Pajnič; Ljubiša Pađen; Nejc Steiner; Veronika Kralj-Iglič; Saba Battelino
Journal:  Front Bioeng Biotechnol       Date:  2021-07-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.